INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51 | -98.5% | 1,615 | -98.1% | 0.00% | -100.0% |
| Q2 2023 | $3,448 | +10.4% | 84,542 | +0.9% | 0.01% | +14.3% |
| Q1 2023 | $3,123 | -4.4% | 83,811 | -10.5% | 0.01% | -12.5% |
| Q4 2022 | $3,268 | -99.9% | 93,690 | +48.5% | 0.01% | -27.3% |
| Q3 2022 | $3,531,000 | -19.7% | 63,101 | -25.7% | 0.01% | -8.3% |
| Q2 2022 | $4,397,000 | -22.7% | 84,956 | +8.6% | 0.01% | 0.0% |
| Q1 2022 | $5,685,000 | -39.8% | 78,228 | -2.1% | 0.01% | -45.5% |
| Q4 2021 | $9,445,000 | +5.3% | 79,884 | +19.5% | 0.02% | -4.3% |
| Q3 2021 | $8,971,000 | – | 66,874 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |